| Literature DB >> 31451297 |
Rafaila Rafique1, Khalid Mohammed Khan2, Sridevi Chigurupati3, Abdul Wadood4, Ashfaq Ur Rehman4, Arunkumar Karunanidhi5, Shehryar Hameed1, Muhammad Taha6, Mariya Al-Rashida7.
Abstract
The current study describes the discovery of novel inhibitors of α-glucosidase and α-amylase enzymes. For that purpose, new hybrid analogs of N-hydrazinecarbothioamide substituted indazoles 4-18 were synthesized and fully characterized by EI-MS, FAB-MS, HRFAB-MS, 1H-, and 13C NMR spectroscopic techniques. Stereochemistry of the imine double bond was established by NOESY measurements. All derivatives 4-18 with their intermediates 1-3, were evaluated for in vitro α-glucosidase and α-amylase enzyme inhibition. It is worth mentioning that all synthetic compounds showed good inhibition potential in the range of 1.54 ± 0.02-4.89 ± 0.02 µM for α-glucosidase and for α-amylase 1.42 ± 0.04-4.5 ± 0.18 µM in comparison with the standard acarbose (IC50 value of 1.36 ± 0.01 µM). In silico studies were carried out to rationalize the mode of binding interaction of ligands with the active site of enzymes. Moreover, enzyme inhibitory kinetic characterization was also performed to understand the mechanism of enzyme inhibition.Entities:
Keywords: Carbothioamide; Hyperglycemia; Indazole; α-amylase; α-glucosidase
Mesh:
Substances:
Year: 2019 PMID: 31451297 DOI: 10.1016/j.bioorg.2019.103195
Source DB: PubMed Journal: Bioorg Chem ISSN: 0045-2068 Impact factor: 5.275